Publikationen, an denen er mitarbeitet Javier Salvador Rodríguez (22)

2021

  1. Endocrine disorders and psychiatric manifestations

    Endocrinology (Switzerland) (Springer Science and Business Media Deutschland GmbH), pp. 311-345

  2. Obesity and COVID-19. A necessary position statement

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 8, pp. 573-576

  3. Resting energy expenditure is not altered in children and adolescents with obesity. Effect of age and gender and association with serum Leptin levels

    Nutrients, Vol. 13, Núm. 4

2019

  1. Discriminatory ability of anthropometric measurements of central fat distribution for prediction of post-prandial hyperglycaemia in patients with normal fasting glucose: The DICAMANO Study NCT03506581 NCT

    Journal of Translational Medicine, Vol. 17, Núm. 1

2018

  1. High Body Adiposity Drives Glucose Intolerance and Increases Cardiovascular Risk in Normoglycemic Subjects

    Obesity, Vol. 26, Núm. 4, pp. 672-682

2017

  1. Control de los factores de riesgo cardiovascular en diabetes tipo 2 en una consulta monográfica

    Anales del sistema sanitario de Navarra, Vol. 40, Núm. 3, pp. 413-420

  2. Dissociation of body mass index, excess weight loss and body fat percentage trajectories after 3 years of gastric bypass: Relationship with metabolic outcomes

    International Journal of Obesity, Vol. 41, Núm. 9, pp. 1379-1387

  3. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?

    European Journal of Internal Medicine, Vol. 41, pp. 74-78

2015

  1. Cardiometabolic Profile Related to Body Adiposity Identifies Patients Eligible for Bariatric Surgery More Accurately than BMI

    Obesity Surgery, Vol. 25, Núm. 9, pp. 1594-1603

2014

  1. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK

    Diabetes, Vol. 63, Núm. 10, pp. 3346-3358

  2. ¿Existe mayor riesgo de diabetes gestacional en pacientes con disfunción tiroidea autoinmune?

    Endocrinologia y Nutricion, Vol. 61, Núm. 7, pp. 377-381

2013

  1. Cardiotrophin 1 protects beta cells from apoptosis and prevents streptozotocin-induced diabetes in a mouse model

    Diabetologia, Vol. 56, Núm. 4, pp. 838-846

  2. Erratum: Cardiotrophin 1 protects beta cells from apoptosis and prevents streptozotocin-induced diabetes in a mouse model (Diabetologia DOI 10.1007/s00125-012-2822-8)

    Diabetologia

2012

  1. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity

    International Journal of Obesity, Vol. 36, Núm. 2, pp. 286-294

  2. Clinical usefulness of a new equation for estimating body fat

    Diabetes Care, Vol. 35, Núm. 2, pp. 383-388

2011

  1. Body adiposity and type 2 diabetes: Increased risk with a high body fat percentage even having a normal BMI

    Obesity, Vol. 19, Núm. 7, pp. 1439-1444

2010

  1. Capítulo 30. El laboratorio en las enfermedades endocrinológicas

    La clínica y el laboratorio: interpretación de análisis y pruebas funcionales, exploración de los síndromes, cuadro biológico de las enfermedades (Elsevier Masson), pp. 587-628

  2. El índice de masa corporal y la circunferencia abdominal infraestiman el diagnóstico de obesidad en pacientes con diabetes mellitus tipo 2

    Avances en Diabetologia, Vol. 26, Núm. 3, pp. 173-177

  3. Importancia del control del peso en el deterioro metabólico de la diabetes tipo 2

    Avances en Diabetologia, Vol. 26, Núm. 3, pp. 151-155

2009

  1. La actividad física determinada mediante acelerometría es menor en los pacientes obesos

    Trauma, Vol. 20, Núm. 2, pp. 83-91